Pfizer expects Covid vaccine sale revenue to go beyond $26 billion
Image Credit: Shortpedia
Leading vaccine manufacturer Pfizer has increased its projections for 2021 revenues and profits from the sale of Covid vaccine to nearly $26 billion from the earlier estimate of $15 billion. "It is our hope that the Pfizer-BioNTech vaccine will continue to have a global impact by helping to get the devastating pandemic under control," Chief Executive Albert Bourla said while adding that he expects "durable demand" for the vaccine.